This week’s Chart of the Week is from Morningstar’s Markets Observer Q2 2025 report. The comprehensive research covers how ...

Looking at a solid core performance, insurance headwinds, and Buffett’s retirement, here’s what we think of Berkshire stock.

David Dreman bought stocks that nobody else wanted. Here are five of his rules for contrarian investing and nine ASX stocks ...

With most Aussies now holding at least one ETF in their portfolio, it’s a hard proposition to ignore for beginner investors.

Jayamanne: And we’ve exaggerated the returns, which shows the impact of breaking the chain of compounding. There is value in ...

The United States and China agreed to temporary tariff cuts for the next 90 days while they negotiate a larger trade deal.

The announcement sent healthcare stocks plunging in Asia and Europe. Takeda Pharmaceutical TAK dropped 6.5% in Tokyo, while ...

Former Assistant Treasurer Stephen Jones was adamant that this will be a minimal change for the majority. He also confirmed that losses can be carried forward to offset future gains. However, the ...

Taken together, Esther thinks that the odds of Redox continuing to grow sales at a double-digit clip look fairly good. Her ...

Microchip is calling the bottom on the brutal cyclical downturn that weighed its the business for the past several quarters.

It says government spending on older people, including the age pension, aged care and health care, has increased ...

Aurizon is at risk of missing the bottom end of the fiscal 2025 EBITDA guidance range of AUD 1.66 billion-AUD 1.74 billion.